Skip to content
Clinical Trials – home
Therapeutic area

Musculoskeletal and connective tissue disorders – page 69

  • 863 clinical trials
  • 359 recruiting
  • 328 conditions
  • 28 countries

Conditions in this area

328 conditions with trials, the busiest first

Clinical trials in Musculoskeletal and connective tissue disorders

863 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

863 clinical trials

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Chloride
  • Sponsor:Hvidovre Hospital
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Risdiplam
  • Sponsor:UZ Leuven

Axial spondyloarthritis+1

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Abt-494
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Tendon disorder

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ngi226
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tildrakizumab
  • Sponsor:Sun Pharmaceutical Industries Limited

Osteoarthritis

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Paradigm Biopharmaceuticals (USA) Inc.

Osteoporosis+1

Not recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dasatinib
  • Sponsor:Odense University Hospital
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Substances:Somapacitan
  • Sponsor:Novo Nordisk A/S
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen Cilag International

Back pain

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aceclofenac
  • Sponsor:Apurano Pharmaceuticals GmbH
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Obexelimab
  • Sponsor:Zenas Biopharma (USA) LLC

Dermatomyositis+1

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Enpatoran
  • Sponsor:Merck Healthcare KGaA

Substances studied in this area

The therapies tested most often in Musculoskeletal and connective tissue disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.